Home » Topics » BioWorld Science

BioWorld Science
RSS

Vidac begins phase IIb trial of VCA-1102 in actinic keratosis

July 11, 2018

Hitgen describes Rho-associated protein kinase inhibitors

July 11, 2018

Dihydroceramide desaturase inhibitors presented by Centaurus Therapeutics

July 11, 2018

Janssen Pharmaceutica discovers new menin/MLL interaction inhibitors

July 11, 2018

Aurigene Discovery Technologies patents BRD4 inhibitors

July 11, 2018

New NFE2L2 activators identified at GlaxoSmithKline

July 11, 2018

Positive phase I results announced for Vivus' VI-0106

July 11, 2018

miRagen launches phase II study of MRG-201

July 11, 2018

Initiation of phase II clinical trial of BPN-14770 in fragile X syndrome

July 11, 2018

New abzymes presented for diagnosing multiple sclerosis

July 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...